- Konstantin Korotkov (College of Medicine) Inhibitors of Papain-like Protease from SARS-CoV-2
- Charles Lutz (College of Medicine) Hypoxia-Induced Dysfunction of Virus-and Fibrosis-Fighting Human NK Cells-A Proposed Cure
- Peter Nagy (College of Agriculture, Food and Environment) Identification of Cellular Targets of Human SARS-COV2 in Yeast
- Jeremy Wood (College of Medicine) Dissecting the Underlying Mechanisms of Hemostatic Dysregulation in COVID-19 Patients
- Beth Garvy (College of Medicine) Longitudinal Study of Immune Responses in COVID-19 Patients
- Joel Hamm and James Keck (College of Medicine) STINCKY: Smell Testing for Infection with Novel Coronavirus in Kentucky
- Becky Dutch (Molecular & Cellular Biochemistry) SARS-CoV-2 SPIKE PROTEIN STABILITY AND FUSION ACTIVITY: ROLES OF PROTEOLYTIC PROCESSING AND KEY RESIDUES:
- Jill Turner (College of Pharmacy) CNS Involvement in the Progression of COVID-19: Preclinical Intervention with NMDA Receptor Antagonists
- Lisa Cassis (Vice President for Research) Sex Differences in COVID-19
- Oleg Tsodikov and Sylvie Garneau-Tsodikova (College of Pharmacy) Development of Ebselen/Ebsulfur Inhibitors of SARS-CoV-2 Main Protease Mpro for COVID-19 therapy
See brief project descriptions on CCTS site